PARSIPPANY, N.J., Jan. 8, 2012 /PRNewswire/ -- Novartis Consumer Health, Inc. (NCH) announced today that it is voluntarily recalling all lots of select bottle packaging configurations of Excedrin® and NoDoz® products with expiry dates of December 20, 2014 or earlier as well as Bufferin® and Gas-X Prevention® products with expiry dates of December 20, 2013 or earlier, in the United States. NCH is taking this action as a precautionary measure because the products may contain stray tablets, capsules, or caplets from other Novartis products, or contain broken or chipped tablets.
The affected bottle sizes are attached to this release. The Novartis Consumer Health Inc. Lincoln, NE facility has voluntarily suspended operations and shipments to accelerate maintenance and other improvement activities at the site.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA).
Mixing of different products in the same bottle could result in consumers taking the incorrect product and receiving a higher or lower strength than intended or receiving an unintended ingredient. This could potentially result in overdose, interaction with other medications a consumer may be taking, or an allergic reaction if the consumer is allergic to the unintended ingredient. NCH is not aware of adverse events reported with the issues leading to the recall.
These over-the-counter products were distributed nationwide to wholesalers and retailers.
Novartis Consumer Health Inc. is notifying its distributors and customers and is arranging for return of all recalled products. Wholesalers and retailers should stop distribution and return the affected product using Novartis Product Return information that is being provided to them.
Consumers that have the product(s) being recalled should stop using the product(s) and contact the Novartis Consumer Relationship Center at 1-888-477-2403 (available Monday-Friday 9 a.m. to 8 p.m. Eastern Time) for information on how to return the affected products and receive a full refund. For more detailed information, consumers should visit our website at www.novartisOTC.com as of January 9, 2012. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using these drug products.
Adverse events that may be related to the use of these products may be reported to FDA's MedWatch Adverse Event Reporting Program either online, by regular mail or by fax:
- Online: www.fda.gov/medwatch/report.htm
- Regular Mail: use postage-paid FDA form 3500 available at:
www.fda.gov/MedWatch/getforms.htm.
Mail to MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787 - Fax: 1-800-FDA-0178
These actions announced today, highlight the strong Novartis commitment to a single quality standard for the Novartis Group. The Novartis Group is making the necessary investments and committing the right resources to ensure these are implemented across the entire Novartis Group network. The high quality of Novartis products and operations has been critical to building the Novartis Group reputation over the past 15 years. Novartis Group is committed to ensuring the highest standard for patients who rely on our products and medicines.
Novartis Consumer Health Inc. plans to gradually resume operations at its Lincoln, NE site following implementation of planned improvements and in agreement with the FDA. The Novartis Consumer Health Inc. Lincoln, NE facility produces a variety of products mainly for the US market with annual sales value of less than 2% of Novartis Group sales. At this stage, it is not possible to determine when the plant will resume full operations and the full financial impact of these events. NCH will take a one-time charge currently estimated at USD 120 million in the fourth quarter of 2011, relating to the recalls and improvement work at the Lincoln, NE facility.
Novartis commitment to quality
The Novartis Group is fully committed to ensuring the quality, safety and integrity of its products. All Novartis Group companies have a clear commitment to patients and Health Authorities to ensure high quality standards for all our products and services. Novartis Group companies stand behind the safety and efficacy of their products, and are fully committed to maintaining high quality standards at all production sites in the US and around the world. All Novartis Group products are subjected to strict manufacturing, testing and monitoring standards. Where they fall outside the standards, Novartis Group companies take actions to correct the issue and may recall products as a precaution.
Disclaimer
The foregoing release contains forward-looking statements that can be identified by terminology such as "potential," "will," "committed," "commitment," "plans," or similar expressions, or by express or implied discussions regarding the potential length of the shutdown of our Lincoln, NE production facility, regarding the potential for any further regulatory actions at the Lincoln, NE production facility, regarding the potential for any further quality issues arising at any additional Novartis manufacturing facilities, or regarding the potential financial impact of the Lincoln, NE facility shutdown. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that our Lincoln, NE production facility will reopen at any particular time. Nor can there be any guarantee that actions described in this release will be the only regulatory actions required at the Lincoln, NE facility. Neither can there be any guarantee that further quality issues will not arise at any additional Novartis Group manufacturing facilities. Nor can there be any guarantee as to the potential financial impact on Novartis resulting from the shutdown of the Lincoln, NE production facility. In particular, management's expectations could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; unexpected manufacturing issues, including unexpected inabilities to satisfy regulators' requirements for the reopening of the Lincoln, NE production facility; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
About Novartis
Novartis Group provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2010, the Group's continuing operations achieved net sales of USD 50.6 billion, while approximately USD 9.1 billion (USD 8.1 billion excluding impairment and amortization charges) was invested in R&D throughout the Group. Novartis Group companies employ approximately 121,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.novartis.com.
Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartis.
Novartis Media Relations
Julie Masow Novartis Corporation +1 212 830 2465 (direct) +1 862 579 8456 (mobile) julie.masow@novartis.com Pamela McKinlay Novartis Consumer Health, Inc. +1 973 503 7337(direct) +1 862 221 0151(mobile) pamela.mckinlay@novartis.com e-mail: us.mediarelations@novartis.com | Milicent Brooks Novartis Consumer Health, Inc. +1 973 503 7483(direct) +1 973 479 2078 (mobile) milicent.brooks@novartis.com |
For Novartis multimedia content, please visit www.thenewsmarket.com/Novartis
For questions about the site or required registration, please contact: journalisthelp@thenewsmarket.com.
Material | Material description | UPC Code | UCC Code | NDC Code | QuantityReturned |
100007332 | Bufferin® Extra Strength Tablets 130CT | 300672065131 | 10300672065138 | 0067206513 | |
100007330 | Bufferin® Extra Strength Tablets 39CT | 300672065391 | 10300672065398 | 0067206539 | |
100007776 | Bufferin® Low Dose Tablets 130CT | 300676424132 | 10300676424139 | 0067642413 | |
100007345 | Bufferin® Regular Strength Tablets 130CT | 300672063137 | 10300672063134 | 0067206313 | |
100008631 | Excedrin® Back & Body Caplets 100CT Account Specific | 300676238920 | 10300676238927 | 0067623891 | |
100008076 | Excedrin®Back&BodyCaplets100CTAccountSpecificNoCarton | 300676238944 | 10300676238941 | 0067623894 | |
100008075 | Excedrin® Back & Body Caplets 100CT New Label | 300676238913 | 10300676238910 | 0067623891 | |
100008073 | Excedrin® Back & Body Caplets 24CT New Label | 300676238241 | 10300676238248 | 0067623824 | |
100008074 | Excedrin® Back & Body Caplets 50CT New Label | 300676238500 | 10300676238507 | 0067623850 | |
100008627 | Excedrin® Extra Strength Caplets 100CT Account Specific | 300672000927 | 10300672000924 | 0067200091 | |
100005995 | Excedrin® Extra Strength Caplets 100CT Account Specific | 300672000941 | 10300672000948 | 0067200094 | |
100008027 | Excedrin® Extra Strength Caplets 100CT Account Specific | 300672000941 | 10300672000948 | 0067200094 | |
100008026 | Excedrin® Extra Strength Caplets 100CT Account Specific | 300672000910 | 10300672000917 | 0067200091 | |
100003160 | Excedrin® Extra Strength Caplets 100CT | 300672000910 | 10300672000917 | 0067200091 | |
100007201 | Excedrin® Extra Strength Caplets 125CT Bonus Pack | 300672000835 | 10300672000832 | 0067200083 | |
100008434 | Excedrin®ExtraStrengthCaplets125CTBonusPackAccountSpecific | 300672000842 | 10300672000849 | 0067200084 | |
100008455 | Excedrin® Extra Strength Caplets 125CT New Carton | 300672000866 | 10300672000863 | 0067200086 | |
100009008 | Excedrin® Extra Strength Caplets 24+6CT Bonus Pack | 300672000309 | 10300672000306 | 0067200030 | |
100003157 | Excedrin® Extra Strength Caplets 24CT | 300672000248 | 10300672000245 | 0067200024 | |
100008024 | Excedrin® Extra Strength Caplets 24CT New Label | 300672000248 | 10300672000245 | 0067200024 | |
100004485 | Excedrin® Extra Strength Caplets 250CT No Carton | 300672000071 | 10300672000078 | 0067200007 | |
100008033 | Excedrin® Extra Strength Caplets 250CT No Carton New Label | 300672000071 | 10300672000078 | 0067200007 | |
100004868 | Excedrin® Extra Strength Caplets 250CT Special Inner | 300672000774 | 10300672000771 | 0067200077 | |
100008029 | Excedrin® Extra Strength Caplets 250CT New Label | 300672000774 | 10300672000771 | 0067200077 | |
100008635 | Excedrin® Extra Strength Caplets 300CT Bonus Pack | 300672000552 | 10300672000559 | 0067200055 | |
100008025 | Excedrin® Extra Strength Caplets 50CT New Label | 300672000507 | 10300672000504 | 0067200050 | |
100003158 | Excedrin® Extra Strength Caplets 50S | 300672000507 | 10300672000504 | 0067200050 | |
100007982 | Excedrin® Extra Strength Express Gel Caps 20CT New Label | 300676270203 | 10300676270200 | 0067627020 | |
100007987 | Excedrin® Extra Strength Express Gel Caps 40CT New Label | 300676270401 | 10300676270408 | 0067627040 | |
100008630 | Excedrin® Extra Strength Express Gel Caps 80CT Account Specific | 300676270814 | 10300676270811 | 0067627080 | |
100007988 | Excedrin® Extra Strength Express Gel Caps 80CT | 300676270807 | 10300676270804 | 0067627080 | |
100007989 | Excedrin® Extra Strength Express Gel Caps 80CT Account Specific | 300676270944 | 10300676270941 | 0067627094 | |
100008037 | Excedrin® Extra Strength Gel Tablets 24CT | 300672021243 | 10300672021240 | 0067202124 | |
100004674 | Excedrin® Extra Strength Tablets 100CT Special Inner | 300672030917 | 10300672030914 | 0067203091 | |
100008626 | Excedrin® Extra Strength Tablets 100CT Account Specific | 300672030931 | 10300672030938 | 0067203091 | |
100008016 | Excedrin® Extra Strength Tablets 100CT Account Specific | 300672030948 | 10300672030945 | 0067203094 | |
100008010 | Excedrin® Extra Strength Tablets 100CT New Label | 300672030917 | 10300672030914 | 0067203091 | |
100007200 | Excedrin® Extra Strength Tablets 125CT Bonus Pack | 300672030832 | 10300672030839 | 0067203083 | |
100008460 | Excedrin® Extra Strength Tablets 125CT Bonus Pack New Carton | 300672030863 | 10300672030860 | 0067203086 | |
100008022 | Excedrin® Extra Strength Tablets 200CT New Label | 300672030924 | 10300672030921 | 0067203092 | |
100009062 | Excedrin® Extra Strength Tablets 24+6CT Bonus Pack | 300672030306 | 10300672030303 | 0067203030 | |
100003181 | Excedrin® Extra Strength Tablets 24CT | 300672030245 | 10300672030242 | 0067203024 | |
100008008 | Excedrin® Extra Strength Tablets 24CT New Label | 300672030245 | 10300672030242 | 0067203024 | |
100008807 | Excedrin® Extra Strength Tablets 250+50CT Bonus Pack | 300672030573 | 10300672030570 | 0067203055 | |
100004173 | Excedrin® Extra Strength Tablets 250CT No Carton | 300672030078 | 10300672030075 | 0067203007 | |
100008031 | Excedrin® Extra Strength Tablets 250CT No Carton New Label | 300672030078 | 10300672030075 | 0067203007 | |
100004869 | Excedrin® Extra Strength Tablets 250CT Special Inners | 300672030771 | 10300672030778 | 0067203077 | |
100008019 | Excedrin® Extra Strength Tablets 250CT New Label | 300672030771 | 10300672030778 | 0067203077 | |
100007470 | Excedrin® Extra Strength Tablets 300CT New Carton | 300672030337 | 10300672030310 | 0067203033 | |
100008472 | Excedrin® Extra Strength Tablets 300CT Club Tray | 300672030337 | 10300672030310 | 0067203033 | |
100008020 | Excedrin® Extra Strength Tablets 300CT New Label | 300672030337 | 10300672030310 | 0067203033 | |
100003134 | Excedrin® Extra Strength Tablets 300S | 300672030337 | 10300672030334 | 0067203033 | |
100003186 | Excedrin® Extra Strength Tablets 50CT | 300672030504 | 10300672030501 | 0067203050 | |
100008009 | Excedrin® Extra Strength Tablets 50CT New Label | 300672030504 | 10300672030501 | 0067203050 | |
100006967 | Excedrin® Extra Strength Tablets 8CT | 300672030085 | 10300672030082 | 0067203008 | |
100008007 | Excedrin® Extra Strength Tablets 8CT New Label | 300672030085 | 10300672030082 | 0067203008 | |
100007967 | Excedrin® Migraine Express Gel Caplets 20CT New Label | 300676341200 | 10300676341207 | 0067634120 | |
100003178 | Excedrin® Migraine Caplets 100CT | 300672039910 | 10300672039917 | 0067203991 | |
100005998 | Excedrin® Migraine Caplets 100CT Account Specific | 300672039941 | 10300672039948 | 0067203994 | |
100008087 | Excedrin® Migraine Caplets 100CT Account Specific No Carton | 300672039941 | 10300672039948 | 0067203994 | |
100008656 | Excedrin® Migraine Caplets 100CT Account Specific | 300672043917 | 10300672043914 | 0067203991 | |
100008086 | Excedrin® Migraine Caplets 100CT New Label | 300672039910 | 10300672039917 | 0067203991 | |
100008443 | Excedrin® Migraine Caplets 125CT Bonus Pack No Carton | 300672039842 | 10300672039849 | 0067203984 | |
100008461 | Excedrin® Migraine Caplets 125CT Bonus Pack New Carton | 300672039866 | 10300672039863 | 0067203986 | |
100007215 | Excedrin® Migraine Caplets 125CT Bonus Pack | 300672039835 | 10300672039832 | 0067203983 | |
100008090 | Excedrin® Migraine Caplets 200CT New Label | 300672039927 | 10300672039924 | 0067203992 | |
100009016 | Excedrin® Migraine Caplets 24+6CT Bonus Pack | 300672039309 | 10300672039306 | 0067203930 | |
100003182 | Excedrin® Migraine Caplets 24CT | 300672039248 | 10300672039245 | 0067203924 | |
100008084 | Excedrin® Migraine Caplets 24CT New Label | 300672039248 | 10300672039245 | 0067203924 | |
100008809 | Excedrin® Migraine Caplets 250+50CT Bonus Pack | 300672039576 | 10300672039573 | 0067203955 | |
100004174 | Excedrin® Migraine Caplets 250CT No Carton | 300672039071 | 10300672039078 | 0067203907 | |
100008093 | Excedrin® Migraine Caplets 250CT No Carton New Label | 300672039071 | 10300672039078 | 0067203907 | |
100004870 | Excedrin® Migraine Caplets 250CT Special Inners | 300672039774 | 10300672039771 | 0067203977 | |
100008091 | Excedrin® Migraine Caplets 250CT New Label | 300672039774 | 10300672039771 | 0067203977 | |
100003121 | Excedrin® Migraine Caplets 300CT | 300672039330 | 10300672039337 | 0067203933 | |
100007469 | Excedrin® Migraine Caplets 300CT New Carton | 300672039330 | 10300672039313 | 0067203933 | |
100008092 | Excedrin® Migraine Caplets 300CT New Label | 300672039330 | 10300672039313 | 0067203933 | |
100008471 | Excedrin® Migraine Caplets 300CT Club Tray | 300672039330 | 10300672039313 | 0067203933 | |
100008085 | Excedrin® Migraine Caplets 50CT New Label | 300672039507 | 10300672039504 | 0067203950 | |
100003185 | Excedrin® Migraine Caplets 50CT | 300672039507 | 10300672039504 | 0067203950 | |
100008079 | Excedrin® Migraine Caplets 8CT New Label | 300672039088 | 10300672039085 | 0067203908 | |
100008015 | Excedrin® Migraine Gel Tablets 160CT | 300672035165 | 10300672035162 | 0067203516 | |
100004681 | Excedrin® Migraine Gel Tablets 100CT Special Inner | 300672035912 | 10300672035919 | 0067203591 | |
100008096 | Excedrin® Migraine Gel Tablets 100CT New Label | 300672035912 | 10300672035919 | 0067203591 | |
100008657 | Excedrin® Migraine Gel Tablets 100CT Account Specific | 300672044914 | 10300672044911 | 0067203591 | |
100008094 | Excedrin® Migraine Gel Tablets 24CT - New Label | 300672035240 | 10300672035247 | 0067203524 | |
100008819 | Excedrin® Migraine Gel Tablets 2X50CT | 300672035936 | 10300672035933 | 0067203593 | |
100008095 | Excedrin® Migraine Gel Tablets 50CT New Label | 300672035509 | 10300672035506 | 0067203550 | |
100004675 | Excedrin® Migraine Tablets 100CT Special Inner | 300672037916 | 10300672037913 | 0067203791 | |
100008082 | Excedrin® Migraine Tablets 100CT New Label | 300672037916 | 10300672037913 | 0067203791 | |
100008437 | Excedrin® Migraine Tablets 125CT Bonus Pack | 300672037831 | 10300672037838 | 0067203783 | |
100009094 | Excedrin® Migraine Tablets 24+6CT Bonus Pack | 300672037305 | 10300672037302 | 0067203730 | |
100003174 | Excedrin® Migraine Tablets 24CT | 300672037244 | 10300672037241 | 0067203724 | |
100008080 | Excedrin® Migraine Tablets 24CT New Label | 300672037244 | 10300672037241 | 0067203724 | |
100004872 | Excedrin® Migraine Tablets 250CT Special Inner | 300672037770 | 10300672037777 | 0067203777 | |
100008083 | Excedrin® Migraine Tablets 250CT New Label | 300672037770 | 10300672037777 | 0067203777 | |
100003173 | Excedrin® Migraine Tablets 50CT | 300672037503 | 10300672037500 | 0067203750 | |
100008081 | Excedrin® Migraine Tablets 50CT New Label | 300672037503 | 10300672037500 | 0067203750 | |
100008049 | Excedrin® PM Caplets 100CT New Label | 300672055910 | 10300672055917 | 0067205591 | |
100008459 | Excedrin® PM Caplets 125CT Bonus Pack New Carton | 300672055866 | 10300672055863 | 0067205586 | |
100008047 | Excedrin® PM Caplets 24CT New Label | 300672055248 | 10300672055245 | 0067205524 | |
100008048 | Excedrin® PM Caplets 50CT New Label | 300672055507 | 10300672055504 | 0067205550 | |
100007146 | Excedrin® PM Express Gel Caplets 20CT | 300676405209 | 10300676405206 | 0067640520 | |
100008632 | Excedrin® PM Express Gel Caplets 80CT Account Specific | 300676405810 | 10300676405817 | 0067640580 | |
100007202 | Excedrin® PM Express Gel Caplets 80CT No Carton | 300676409801 | 10300676409808 | 0067640980 | |
100007148 | Excedrin® PM Express Gel Caplets 80CT New Label | 300676405803 | 10300676405800 | 0067640580 | |
100008629 | Excedrin® PM Tablets 100CT Account Specific | 300672053923 | 10300672053920 | 0067205391 | |
100008065 | Excedrin® PM Tablets 100CT Account Specific No Carton | 300672053947 | 10300672053944 | 0067205394 | |
100008064 | Excedrin® PM Tablets 100CT New Label | 300672053916 | 10300672053913 | 0067205391 | |
100008449 | Excedrin® PM Tablets 125CT Bonus Pack | 300672053831 | 10300672053838 | 0067205383 | |
100009095 | Excedrin® PM Tablets 24+6CT Bonus Pack | 300672053305 | 10300672053302 | 0067205330 | |
100008051 | Excedrin® PM Tablets 24CT New Label | 300672053244 | 10300672053241 | 0067205324 | |
100008063 | Excedrin® PM Tablets 50CT New Label | 300672053503 | 10300672053500 | 0067205350 | |
100008046 | Excedrin® PM Tablets 8CT New Label | 300672053084 | 10300672053081 | 0067205308 | |
100008040 | Excedrin® Sinus Headache Caplets 24CT New Label | 300672062246 | 10300672062243 | 0067206224 | |
100004691 | Excedrin® Tension Headache Caplets 100CT Special Inner | 300672045911 | 10300672045918 | 0067204591 | |
100006001 | Excedrin®TensionHeadacheCaplets100CTAccountSpecificNoCarton | 300672045942 | 10300672045949 | 0067204594 | |
100008057 | Excedrin® Tension Headache Caplets 100CT Account Specific No Carton New Label | 300672045942 | 10300672045949 | 0067204594 | |
100008628 | Excedrin® Tension Headache Caplets 100CT Account Specific | 300672045959 | 10300672045956 | 0067204591 | |
100008056 | Excedrin® Tension Headache Caplets 100CT New Label | 300672045911 | 10300672045918 | 0067204591 | |
100008442 | Excedrin® Tension Headache Caplets 125CT Bonus Pack | 300672045836 | 10300672045833 | 0067204583 | |
100008453 | Excedrin® Tension Headache Caplets 125CT Bonus Pack No Carton | 300672045843 | 10300672045840 | 0067204584 | |
100009007 | Excedrin® Tension Headache Caplets 24+6CT Bonus Pack | 300672045300 | 10300672045307 | 0067204530 | |
100004689 | Excedrin® Tension Headache Caplets 24CT Special Inner | 300672045249 | 10300672045246 | 0067204524 | |
100008068 | Excedrin® Tension Headache Caplets 24CT New Label | 300672045249 | 10300672045246 | 0067204524 | |
100003209 | Excedrin® Tension Headache Caplets 250CT | 300672045775 | 10300672045772 | 0067204577 | |
100004406 | Excedrin® Tension Headache Caplets 250CT No Carton | 300672045072 | 10300672045079 | 0067204507 | |
100004690 | Excedrin® Tension Headache Caplets 50CT Special Inner | 300672045508 | 10300672045505 | 0067204550 | |
100008069 | Excedrin® Tension Headache Caplets 50CT New Label | 300672045508 | 10300672045505 | 0067204550 | |
100007978 | Excedrin® Tension Headache Express Gel Caplets 20CT | 300676272207 | 10300676272204 | 0067627220 | |
100007979 | Excedrin® Tension Headache Express Gel Caplets 40CT | 300676272405 | 10300676272402 | 0067627240 | |
100007981 | Excedrin®TensionHeadacheExpressGelCaplets80CTAccountSpecific | 300676272948 | 10300676272945 | 0067627294 | |
100007980 | Excedrin® Tension Headache Express Gel Caplets 80CT | 300676272801 | 10300676272808 | 0067627280 | |
100008060 | Excedrin® Tension Headache Gel Tablets 24CT New Label | 300672050243 | 10300672050240 | 0067205024 | |
100007153 | Gas-X® Prevention® Caplets 20CT | 300433005208 | 10300433005205 | N/A | |
100007154 | Gas-X® Prevention® Caplets 50CT | 300433005505 | 10300433005502 | N/A | |
100004719 | NoDoz® Maximum Strength Caplets 16CT | 300672070166 | 10300672070163 | 0067207016 | |
100008716 | NoDoz® Maximum Strength Caplets 16CT New Graphic | 300672070166 | 10300672070163 | 0067207016 | |
100004720 | NoDoz® Maximum Strength Caplets 36CT | 300672070364 | 10300672070361 | 0067207036 | |
100008715 | NoDoz® Maximum Strength Caplets 36CT New Graphic | 300672070364 | 10300672070361 | 0067207036 | |
100004721 | NoDoz® Maximum Strength Caplets 60CT | 300672070609 | 10300672070606 | 0067207060 | |
100008717 | NoDoz® Maximum Strength Caplets 60CT New Graphic | 300672070609 | 10300672070606 | 0067207060 |
SOURCE Novartis Consumer Health, Inc.
